Device type · GJS
Test, Time, Prothrombin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GJS
Hematology
Device class
Class II
FDA decisions since 2015
16
510(k), De Novo and PMA
Adverse event reports
172
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Test, Time, Prothrombin
- Product code
- GJS
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7750
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for GJS
Latest FDA decisions
The 8 newest of 16 since 2015.
- CoaguChek XS Plus System510(k)
K253188 · Decided Oct 24, 2025 · 28 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- microINR System510(k)
K251564 · Decided Jul 21, 2025 · 60 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- microINR System510(k)
K243543 · Decided Feb 27, 2025 · 104 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Universal Biosensors Pty, Ltd.
K230802 · Decided Mar 15, 2024 · 358 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
K220282 · Decided Jul 14, 2023 · 528 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- microINR System510(k)
K231711 · Decided Jul 11, 2023 · 29 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- STA- NeoPTimal510(k)
K211485 · Decided Dec 23, 2022 · 589 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
K212779 · Decided Oct 5, 2022 · 399 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Reports received
172
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
158
92% of reports
Injury reports
14
8.1% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 29 | 1 | 0 | 0 |
| Jan 24 | 13 | 1 | 0 | 0 |
| Feb 24 | 12 | 0 | 0 | 0 |
| Mar 24 | 10 | 0 | 0 | 0 |
| Apr 24 | 14 | 0 | 0 | 0 |
| May 24 | 9 | 2 | 0 | 0 |
| Jun 24 | 7 | 1 | 0 | 0 |
| Jul 24 | 17 | 1 | 0 | 0 |
| Aug 24 | 23 | 2 | 0 | 0 |
| Sep 24 | 13 | 1 | 0 | 0 |
| Oct 24 | 16 | 1 | 0 | 0 |
| Nov 24 | 13 | 1 | 0 | 0 |
| Dec 24 | 16 | 5 | 0 | 0 |
| Jan 25 | 4 | 0 | 0 | 0 |
| Feb 25 | 15 | 0 | 0 | 0 |
| Mar 25 | 10 | 1 | 0 | 0 |
| Apr 25 | 15 | 1 | 0 | 0 |
| May 25 | 4 | 0 | 0 | 0 |
| Jun 25 | 6 | 0 | 0 | 0 |
| Jul 25 | 9 | 0 | 0 | 0 |
| Aug 25 | 7 | 0 | 0 | 0 |
| Sep 25 | 9 | 1 | 0 | 0 |
| Oct 25 | 6 | 2 | 0 | 0 |
| Nov 25 | 7 | 0 | 0 | 0 |
| Dec 25 | 8 | 1 | 0 | 0 |
| Jan 26 | 10 | 2 | 0 | 0 |
| Feb 26 | 9 | 1 | 0 | 0 |
| Mar 26 | 8 | 3 | 0 | 0 |
| Apr 26 | 19 | 0 | 0 | 0 |
| May 26 | 6 | 2 | 0 | 0 |
| Jun 26 | 21 | 1 | 0 | 0 |
| Jul 26 | 20 | 1 | 0 | 0 |
| Aug 26 | 18 | 0 | 0 | 0 |
| Sep 26 | 20 | 1 | 0 | 0 |
| Oct 26 | 12 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Non Reproducible Results114
- High Test Results26
- Device Difficult to Setup or Prepare24
- Adverse Event Without Identified Device or Use Problem15
- Incorrect, Inadequate or Imprecise Result or Readings7
- Low Test Results6
- No Device Output5
- Circuit Failure2
- Lack of Maintenance Documentation or Guidelines2
- Battery Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions147
- Thrombosis/Thrombus7
- Coagulation Disorder4
- Hematuria2
- Insufficient Information2
- Ischemia Stroke2
- Loss of Vision2
- Retinal Injury2
- Stroke/CVA2
- Transient Ischemic Attack2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays.Open, Classified
Z-1502-2025 · Started Mar 6, 2025 · Posted by FDA Mar 31, 2025
Reason given: The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.
Cause as FDA categorized it: Employee error
- Pacific Hemostasis Thromboplastin-D, 10 ml. Used in performing one-stage prothrombin time test and factor assays.Open, Classified
Z-1503-2025 · Started Mar 6, 2025 · Posted by FDA Mar 31, 2025
Reason given: The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.
Cause as FDA categorized it: Employee error
Mckesson Medical-Surgical Inc. Corporate Office
Z-1583-2022 · Started May 25, 2022 · Posted by FDA Aug 26, 2022
Reason given: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Cause as FDA categorized it: Environmental control
- HemosIL ReadiPlasTin, Part No. 0020301400Open, Classified
Z-1052-2022 · Started Apr 8, 2022
Reason given: Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically HemosIL RecombiPlasTin 2G.
Cause as FDA categorized it: Under Investigation by firm
- HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reagent.Open, Classified
Z-0276-2022 · Started Oct 13, 2021 · Posted by FDA Nov 23, 2021
Reason given: The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or do not pass for each vial of reagent, there is a potential risk of reporting an erroneous result.
Cause as FDA categorized it: Under Investigation by firm
Roche Diagnostics Operations, Inc.
Z-0803-2021 · Started Dec 2, 2020 · Posted by FDA Jan 7, 2021
Reason given: Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Cause as FDA categorized it: Device Design
Roche Diagnostics Operations, Inc.
Z-0804-2021 · Started Dec 2, 2020 · Posted by FDA Jan 7, 2021
Reason given: Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Cause as FDA categorized it: Device Design
Z-0787-2019 · Started Dec 20, 2018 · Posted by FDA Feb 1, 2019
Reason given: Potential for abnormally high INR test results with the CoaguChek XS PT Test Strips for customers who purchased products directly from Terrific Care LLC dba MedEx Supply via website/telephone/facsimile.
Cause as FDA categorized it: Nonconforming Material/Component
Showing the 8 newest of 73 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.